The World Health Organization reporting system for pancreaticobiliary cytopathology
MB Pitman, BA Centeno, MD Reid, MT Siddiqui… - Acta Cytologica, 2023 - karger.com
Abstract The World Health Organization (WHO), the International Academy of Cytology, and
the International Agency for Research on Cancer, with expert contributors from around the …
the International Agency for Research on Cancer, with expert contributors from around the …
What is appropriate care? An integrative review of emerging themes in the literature
J Robertson-Preidler, N Biller-Andorno… - BMC health services …, 2017 - Springer
Background Health care improvement efforts should be aligned in order to make a
meaningful impact on health systems. Appropriate care delivery could be a unifying goal to …
meaningful impact on health systems. Appropriate care delivery could be a unifying goal to …
Repeat EUS-FNA of pancreatic masses after nondiagnostic or inconclusive results: systematic review and meta-analysis
A Lisotti, L Frazzoni, L Fuccio, M Serrani… - Gastrointestinal …, 2020 - Elsevier
Background and Aims EUS-guided FNA (EUS-FNA) is the criterion standard for the
diagnosis of solid pancreatic lesions. Several studies assessed the role of repeat EUS-FNA …
diagnosis of solid pancreatic lesions. Several studies assessed the role of repeat EUS-FNA …
Diagnostic yield of repeat endoscopic ultrasound-guided fine needle biopsy for solid pancreatic lesions
Simple Summary Histological sampling is the cornerstone of diagnosis for patients with solid
pancreatic lesions. Endoscopic ultrasound guided fine needle biopsy (EUS FNB) is the most …
pancreatic lesions. Endoscopic ultrasound guided fine needle biopsy (EUS FNB) is the most …
[HTML][HTML] Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials
QP Janssen, R Quispel, MG Besselink, BA Bonsing… - HPB, 2023 - Elsevier
Abstract (200 words) BACKGROUND Neoadjuvant treatment for pancreatic ductal
adenocarcinoma (PDAC) has increased, necessitating histopathologic confirmation of …
adenocarcinoma (PDAC) has increased, necessitating histopathologic confirmation of …
Neoadjuvant therapy vs. upfront surgery for resectable pancreatic cancer: An update on a systematic review and meta-analysis
Y Xu, Y Chen, F Han, J Wu, Y Zhang - Bioscience trends, 2021 - jstage.jst.go.jp
The effectiveness of neoadjuvant therapy (NAT) remains controversial in the treatment of
pancreatic cancer (PC). Therefore, this meta-analysis aimed to investigate the clinical …
pancreatic cancer (PC). Therefore, this meta-analysis aimed to investigate the clinical …
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
K Winter, R Talar-Wojnarowska, A Dąbrowski… - Gastroenterology …, 2019 - termedia.pl
These recommendations refer to the current management in pancreatic ductal
adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely …
adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely …
Impact of biopsy attempts, race, and access on time to initiation of treatment for pancreatic cancer
RP Bohan, AN Riner, KM Herremans, H Gao… - Journal of …, 2023 - Elsevier
Background Biopsy of suspected pancreatic cancer (PDAC) in surgical candidates is
informative however not always necessary. Biopsies impact treatment options as histological …
informative however not always necessary. Biopsies impact treatment options as histological …
A multimodal imaging study to highlight elastin-derived peptide pro-tumoral effect in a pancreatic xenograft model
L Nannan, W Gsell, S Belderbos, C Gallet… - British Journal of …, 2023 - nature.com
Background Pancreatic ductal adenocarcinoma (PDAC) is highly malignant with a very poor
prognosis due to its silent development and metastatic profile with a 5-year survival rate …
prognosis due to its silent development and metastatic profile with a 5-year survival rate …
[HTML][HTML] Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive …
Methods Of 5,894 patients subjected to EUS-FNA/B, 237 (4.0%) with an initially inconclusive
diagnosis of SPLs were retrospectively enrolled from five tertiary medical centers between …
diagnosis of SPLs were retrospectively enrolled from five tertiary medical centers between …